Cargando…
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr(701) phosphorylation
ERBB2 is a ligand-less tyrosine kinase receptor expressed at very low levels in normal tissues; when overexpressed, it is involved in malignant transformation and tumorigenesis in several carcinomas. In cancer cells, ERBB2 represents the preferred partner of other members of the ERBB receptor family...
Autores principales: | Gaviraghi, Marco, Rabellino, Andrea, Andolfo, Annapaola, Brand, Matthias, Brombin, Chiara, Bagnato, Paola, De Feudis, Giuseppina, Raimondi, Andrea, Locatelli, Alberta, Tosoni, Daniela, Mazza, Davide, Gianni, Luca, Tonon, Giovanni, Yarden, Yosef, Tacchetti, Carlo, Daniele, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547737/ https://www.ncbi.nlm.nih.gov/pubmed/33037285 http://dx.doi.org/10.1038/s41598-020-73835-1 |
Ejemplares similares
-
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr(701) phosphorylation
por: Gaviraghi, Marco, et al.
Publicado: (2021) -
MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK‐mediated HER2 phosphorylation at Thr701
por: Chen, Chia‐Hung, et al.
Publicado: (2017) -
Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor– and ErbB2-positive Breast Cancer
por: Viganò, Lucia, et al.
Publicado: (2022) -
Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells
por: Bagnato, Paola, et al.
Publicado: (2017) -
Time allocation to R 701
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1974)